MURPHY NICOLE (Head of Pharm Ops and Tech) purchased 0.0% of their position (3.00 shares) of BIOGEN INC. on the open market
Open‑market purchase worth $585.11 — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/17/2026ACC: 0000875045-26-000033
Officer· Head of Pharm Ops and Tech
Since Feb 2022
+10.56K
Net shares
Net buyer
$585.11
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
10.56K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3.00
Price / share
$195.03
Trade value
$585.11
% of position
0.0%
2/12/2026
19.61K→19.61K
Total
Net shares
+3.00
Net value
$585.11
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/12/2026 | P · Purchase | +3.00 | $195.03 | $585.11 | 0.0% | 19.61K | 19.61K |
| Total | +3.00 | $585.11 | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
10.56K shares
Shares
+10.56K
Strike price
0
Held after
10.56K
Exercisable
—
2/13/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock10.56K shares | 2/13/2026 | A · Award | +10.56K | 0 | — | 10.56K |